IL-6 is likely to be the main driver, acting synergistically with other interleukins to increase thrombopoietin, of which visceral adipose tissue itself may be an additional source of thrombopoietin, which in turn stimulates megakaryocyte production, leading to thrombocytosis. The gene discussed is IL6; the disease is Thrombocytosis.